V

Vaxart
D

VXRT

0.44840
USD
0.02
(4.52%)
مغلق
حجم التداول
6,310
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
102,328,595
أصول ذات صلة
BNTX
BNTX
2.530
(2.47%)
105.000 USD
I
INO
0.03000
(1.59%)
1.91500 USD
MRNA
MRNA
0.600
(2.22%)
27.590 USD
N
NVAX
0.01000
(0.16%)
6.41000 USD
PFE
PFE
0.065
(0.27%)
24.185 USD
المزيد
الأخبار المقالات

العنوان: Vaxart

القطاع: Healthcare
الصناعة: Biotechnology
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.